CMCO

Good pond, subordinated fish: CMCO/Kito Crosby is now a top-2 global pure-play in intelligent lifting and motion solutions within a $34-44B growing market — but common equity at $447M market cap is a deeply subordinated residual beneath ~$3.35B of obligations at peak leverage. The business quality is real; the capital structure risk is the dominant variable for common shareholders.

Snapshot

What It Does

Columbus McKinnon designs and manufactures material-handling and motion-control products: overhead cranes, hoists, rigging hardware (shackles, blocks, hooks), precision conveyance systems (montrac/montratec automated carrier platforms), linear actuators, and associated digital controls. Products span construction, aerospace, defense, food/beverage, energy, and EV manufacturing. The company has a 120+ year operating history based in Amherst, NY.

In February 2026, CMCO completed the $2.7B acquisition of Kito Crosby — combining Kito's overhead hoist heritage (Japanese-American), Crosby's global rigging hardware brand, and CMCO's precision conveyance platform into a combined entity with ~$2.0B pro forma revenue and operations across Americas, EMEA, and APAC.

What It's Planning

The strategic agenda for FY2026-FY2028 has three pillars:

1. Integration and synergy capture: $70M identified cost synergy run-rate by year 3, with ~20% ($14M) targeted in year 1. Integration management office staffed October 2025. The program is management's own characterization of "naturally back-end loaded."

2. Deleveraging: Target net leverage below 4x by end of FY2028, longer-term below 2x. Mechanism: combined FCF generation plus $160M net divestiture proceeds (US power chain hoist operations sold to Pacific Avenue Capital Partners, closed March 4, 2026, proceeds applied to Term Loan B) plus synergy-enhanced EBITDA.

3. Platform expansion: Scale montrac precision conveyance into APAC via Kito Crosby's regional presence; deepen automation content across the hoist and crane portfolio. The PowerCo (Volkswagen battery) partnership positions CMCO as global intralogistics provider for EV gigafactories — management cited $100M+ order pipeline potential over multiple years, but this is pipeline, not booked backlog.

Catalysts & Demand Drivers

Near-term:

• June 4, 2026 — Q4 FY26 earnings + first FY27 combined guidance (imminent; the single highest-impact event)
• Year-1 synergy tracking confirmation at or ahead of $14M run-rate (~FY27 H1)
• $160M divestiture proceeds already applied to Term Loan B (March 4, 2026 — completed catalyst)
• Tariff headwind neutrality targeted H2 FY26 / FY27

Structural (18-36 months):

• Deleveraging to below 4x net leverage (FY2028 target)
• Precision conveyance / montrac platform scaling in EV and semiconductor verticals
• Resolution of CD&R $800M convertible preferred overhang

Demand backdrop: Crane and hoist TAM projected at $43.85B by 2030, ~5.7% CAGR (GlobeNewsWire, January 2026). US manufacturing reshoring, labor-scarcity-driven automation, and energy transition infrastructure are the structural drivers. Caution: FY2025 standalone revenue fell 5% despite these tailwinds — cyclical softness (EMEA, short-cycle) overrode structural positives in the near term.

Track Record

Revenue (FY, $M):

All figures from SEC EDGAR XBRL fact sheet.

The revenue trajectory shows a clear cyclical pattern: COVID trough in FY2021 (-20% from FY2019 peak), recovery through FY2024 peak, then a fresh 5% decline in FY2025. Operating income and OCF have both compressed materially in FY2025, consistent with EMEA softness and deal-related costs.

Balance sheet / runway:

• FY2025 year-end cash: $53.7M (down from $114M in FY2024 and $133M in FY2023)
• Standalone CMCO standalone OCF: $45.6M in FY2025 — this does NOT service the combined entity's estimated ~$130-150M/year cash interest burden. The combination is only financially viable if the ~$440-460M pro forma EBITDA materializes and synergies contribute on schedule.
• Combined entity funded debt: ~$2.55B ($1.65B Term Loan B + $900M 7.125% senior secured notes due 2033) per management disclosure — not yet in XBRL fact sheet, sourced from Q3 FY26 10-Q.

Share count / dilution:

• Common shares: 28.6M (FY2025 10-K, March 31, 2025), up 48% from 19.4M in FY2012
• Acquisition-driven step-up: ~24.0M to ~28.5M around the FY2022 Dorner acquisition
• CD&R preferred: 21.2M+ potential new shares on conversion (~42.5% of as-converted capitalization) — this would represent approximately 74% dilution to current common shareholders if the full conversion occurred

Valuation

At $15.83/share and $447M market cap:

• Market cap / pro forma adjusted EBITDA (~$486M management guidance): ~0.9x — extremely low but the framing is misleading; this is equity cap to EBITDA, not EV/EBITDA. Enterprise value includes ~$2.55B of debt, making EV/EBITDA approximately 6-7x on the combined business — not obviously cheap for a cyclical industrial with peak leverage.
• Price vs. own history: Stock peaked near $46 (FY2022 cycle high) and traded ~$33 pre-deal announcement (February 2025). The ~42% single-day drop in February 2025 (deal announcement + Q3 FY25 earnings miss) has been followed by further erosion to $15.83 — a total drawdown of ~65% from peak.
• Peer context: Timken (TKR, ~$8.3B market cap) trades at ~20%+ adjusted EBITDA margin with lower leverage. Konecranes (Finnish-listed) operates at ~8-10% EBIT margin but has a stronger service/aftermarket mix. CMCO's 15.6% standalone adjusted EBITDA margin (FY2025) and current leverage make it an outlier in the peer set — either a value trap or a recovery story.

Fair value range: $13-$27

• Bear anchor ($13-$15): DA Davidson Neutral/$15 PT; DCF cross-check shows near-zero equity value if leverage slips past FY2028. $13 represents the scenario where synergy capture falls behind and the preferred overhang compounds.
• Bull anchor ($24-$27): JP Morgan $27 PT; requires credible FY27 guidance plus year-1 synergy confirmation and visible leverage path to below 4x. The $24-$27 range assumes execution tracks on schedule over 18-24 months.
• Method: analyst PT anchoring plus internal leverage-compression math (at 4x net leverage on $460M EBITDA, EV ~$1.84B; subtract ~$2.1B net debt at FY2028 → equity near zero, confirming the upside only exists if synergies and FCF are both delivered). Forward combined FCF not available from XBRL data; full DCF not justifiable from available inputs alone.

Ownership & Insiders

• CD&R (private equity): $800M Series A perpetual convertible preferred, 3 board seats, ~42.5% as-converted stake. This is the dominant ownership feature — a private equity firm effectively controls the company's strategic direction and has priority claim on value over common equity.
• Insider ownership: Not quantified from the XBRL fact sheet; typical for a company of this size to have modest insider common equity ownership given the management team did not fund the deal personally.
• Institutional coverage: ~5 sell-side analysts (JP Morgan, DA Davidson, Wells Fargo). Thin coverage leaves the stock prone to large moves on single estimate revisions — as demonstrated by the February 2025 one-day 42% decline.
• Share buybacks: None identified given the capital structure; all FCF directed toward debt service and deleveraging. This is not a shareholder-return story in the near term.
• Short interest: ~4.5% of float (MarketBeat, November 2025) — elevated but not extreme; not indicative of an active bear case squeeze setup.

Bull Case

At $447M equity market cap, the common is priced as though the Kito Crosby combination permanently impairs value. The mispricing case:

1. The $160M divestiture is a locked-in win. The US power chain hoist sale (March 4, 2026) already reduced Term Loan B with zero remaining execution risk. Plus a $25M earnout if the divested business meets FY2027-28 revenue thresholds.

2. The equity is below 1x pro forma EBITDA. At ~$486M management-guided combined adjusted EBITDA vs. $447M equity market cap, the common is priced like distressed debt. If the company merely survives and deleverages, the re-rating is dramatic — each full turn of leverage reduction on ~$2.55B of debt frees roughly $100M+ of equity value.

3. Precision conveyance is a high-quality embedded growth asset. Montrac/montratec grew 19% YoY in FY2025 and serves semiconductor, EV, and life sciences verticals that are structurally growing. This platform exists inside a stock priced purely on leverage fear.

4. JP Morgan's $27 price target implies 70% upside — a credible institutional view that the current price is excessively discounting the execution risk.

5. Record $1B orders in FY2025 (CMCO FY2025 earnings release) indicates underlying demand existed even as reported revenue softened. The order book supports a revenue recovery thesis in the combined entity.

Bear Case & Red Flags

RED FLAG 1 — Debt load is near-existential for common equity (HIGH severity) Combined entity carries ~$2.55B funded debt plus $800M CD&R preferred = ~$3.35B total obligations. Cash interest on funded debt alone is estimated at ~$130-150M/year (Term Loan B + $900M notes at 7.125%). Standalone CMCO's FY2025 operating cash flow was only $45.6M — the combined entity is only serviceable at the ~$440-460M pro forma EBITDA level. No margin for error.

RED FLAG 2 — CD&R preferred: compounding 42.5% dilution claim (HIGH severity) The $800M 7% perpetual convertible preferred ($56M/year coupon, can be PIK-compounding) represents 21.2M+ potential new shares — approximately 74% dilution to current common. A "Triggering Event" (not publicly defined) escalates the coupon to 10% ($80M/year). CD&R's 3 board seats give it blocking power on major transactions.

RED FLAG 3 — Standalone financials were deteriorating before close (HIGH severity) FY2025 standalone revenue -5% YoY ($963M from $1,013M). Operating income -49% ($55M from $107M). Net loss of $5.1M — first loss in the available 4-year EDGAR record. Cash fell $60M in one year to $53.7M. The entity that took on $2.55B of debt was already cash-light entering the combination.

RED FLAG 4 — Integration at unprecedented scale (HIGH severity) The $70M synergy target requires integrating three distinct operating cultures (CMCO precision conveyance, Kito Japanese hoist heritage, Crosby rigging hardware) across three continents and multiple ERP systems. Integration management office only staffed October 2025, four months before February close. Regulatory information-sharing restrictions prevented detailed pre-close financial diligence on Kito Crosby. Prior largest deal (Dorner, ~$485M) was 5.6x smaller.

RED FLAG 5 — Cyclicality has already bitten; leverage magnifies the next downturn (HIGH severity) FY2020 revenue -7.7% to $809M; FY2021 revenue -20% to $650M during COVID. FY2025 -5% despite macro tailwinds. In a 20% revenue decline from the $2B pro forma base, EBITDA could fall to $290-310M against $130-150M cash interest — leaving almost nothing for common equity.

RED FLAG 6 — Tariff exposure on Japan-heavy supply chain (MEDIUM severity) Kito's manufacturing is heavily Japan-based. US-Japan tariff policy remains fluid. Management guided $0.20-$0.30/share EPS headwind H1 FY26 and targets neutrality by H2 FY26/FY27, but the combined entity's supply chain complexity raises execution risk beyond the standalone CMCO baseline.

RED FLAG 7 — Cash runway critically depleted at deal close (MEDIUM severity) FY2025 year-end cash of $53.7M is the lowest since FY2016 ($51.6M) and represents less than two months of the combined entity's estimated quarterly interest obligation. The $160M net divestiture proceeds improved this, but structural cash drain from interest is large and ongoing.

Interesting Findings

• The Kito Crosby acquisition was announced the same day as the Q3 FY25 earnings miss that triggered the ~42% single-day stock decline (February 2025) — an unusual sequencing that raises the question of whether the deal announcement was designed to shift narrative away from the operational disappointment.
• The fact sheet records 191,171,428 shares at end-FY2011 vs. 19,400,526 at end-FY2012 — a ~10:1 ratio that reflects a historical share reclassification (not a reverse split indicative of distress). The current comparable series starts FY2012.
• Operating cash flow peaked at $106.8M in FY2020 (COVID year) — suggesting CMCO actually benefits from working capital timing during demand troughs before the revenue decline flows through fully.
• No going-concern language appears in the most recent 10-K (filed May 28, 2025). No auditor qualification or material weakness disclosed. No promotion signals identified. Short interest ~4.5% of float — elevated but not extreme.
• The precision conveyance segment (montrac/montratec) represents CMCO's highest-growth, highest-margin embedded asset — growing 19% YoY in FY2025 — yet is buried inside a stock priced primarily on leverage fears from the hoist/crane hardware business.

The Read

CMCO is a genuine business — 120+ years of operations, real products, a credible market position — that has engineered itself into one of the most leveraged capital structures in US industrials through the Kito Crosby combination. The common equity is a binary option on flawless execution: if $70M of synergies are captured on schedule, the $160M divestiture proceeds accelerate deleveraging, and demand holds at or near the ~$2B pro forma base, the stock re-rates materially (toward $24-$27). If any one of those conditions fails — a demand recession, integration stumble, synergy shortfall, or tariff re-escalation — the equity value compresses toward the DA Davidson bear case ($15 or below) and the CD&R preferred compounds against common holders.

The June 4, 2026 Q4 FY26 earnings release is the make-or-break near-term event. It will be the first combined-company guidance print and the first public synergy progress update. Two months of combined operations (since February 4, 2026 close) is not enough time to know with confidence whether integration is tracking — but management will be asked to commit to a FY27 baseline that the market will trade against for the next 12 months.

This is not a quality compounder; it is a leveraged restructuring story with a cyclical industrial substrate. The appropriate frame is: how much execution risk am I comfortable bearing for the potential re-rating? At $15.83, with the thesis hinging on events two to three years out, the answer is investor-specific — but the risk is front-loaded and the payoff is backend-loaded.

Research, not investment advice. Figures sourced from SEC filings and public data; verify before acting.